RAPT Therapeutics
Why Robinhood?
You can watch RAPT and buy or sell other stocks, ETFs, and their options commission-free!About RAPT
Rapt Therapeutics, Inc. operates as a clinical stage immunology-based biopharmaceutical company, which engages in the discovery, development, and commercialization of oral small molecule therapies for patients in oncology and inflammatory diseases. The company was founded in 2015 and is headquartered in South San Francisco, CA.
RAPT Key Statistics
Stock Snapshot
The current RAPT Therapeutics(RAPT) stock price is $10.52, with a market capitalization of 291.52M. The stock trades at a price-to-earnings (P/E) ratio of -5.24.
On 2026-03-06, RAPT Therapeutics(RAPT) stock opened at —, reached a high of —, and a low of —.
The RAPT Therapeutics(RAPT)'s current trading volume is 0, compared to an average daily volume of 1.76M.
During the past year, RAPT Therapeutics(RAPT) stock moved between $5.67 at its lowest and $58.02 at its peak.
During the past year, RAPT Therapeutics(RAPT) stock moved between $5.67 at its lowest and $58.02 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.